/Companies

MultiValent Biotherapies

Los Altos, US · Founded 2025 · Delaware corporation

Find your way into MultiValent Biotherapies

Sign up to see every warm intro you have to MultiValent Biotherapies

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the MultiValent Biotherapies team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

FM
Fred Max SchwarzerNamed on SEC filing
DR
Deborah Robbins SchwarzerNamed on SEC filing
SS
Stephen SnowdyNamed on SEC filing
BK
Bruce KeytNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$10M disclosed across 2 rounds · 2026

▶$10MraisedMar 2026 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Fred SchwarzerExecutive Officer, Director, Promoter
  • Stephen SnowdyExecutive Officer, Director, Promoter
  • Bruce KeytExecutive Officer, Director, Promoter
  • Deborah Robbins SchwarzerExecutive Officer, Director, Promoter
Amount sold
$10M
Minimum investment
$12.5K
First sale
Jan 2026
Incorporated
Corporation, Delaware, 2025
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.4KraisedFeb 2026 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Fred Max SchwarzerExecutive Officer, Director, Promoter
  • Deborah Robbins SchwarzerExecutive Officer, Director, Promoter
  • Stephen SnowdyExecutive Officer, Director, Promoter
  • Bruce KeytExecutive Officer, Director, Promoter
Offering amount
$4.4K
Amount sold
$4.4K
Minimum investment
$50
First sale
Jan 2026
Incorporated
Corporation, Delaware, 2025
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has MultiValent Biotherapies raised?
MultiValent Biotherapies has disclosed $10M raised across 2 rounds.
Where is MultiValent Biotherapies headquartered?
MultiValent Biotherapies is headquartered in Los Altos, US.